← Back
Data updated: Mar 10, 2026
SETON PHARMS
Oncology
SETON PHARMS is a generic drug manufacturer focused on Oncology.
2017
Since
3
Drugs
-
Trials
7
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
MEMANTINE HYDROCHLORIDE 2025-08-28
MEMANTINE HYDROCHLORIDE 2025-04-25
Labeling
MEMANTINE HYDROCHLORIDE 2025-04-18
Manufacturing (CMC)
CAPTOPRIL 2024-08-13
Labeling
CAPTOPRIL 2024-08-13
Labeling
CAPTOPRIL 2024-07-08
Labeling
MEMANTINE HYDROCHLORIDE 2024-05-17
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (2)
Company Info
- First Approval
- 2017-09-28
- Latest
- 2020-08-31
- Applications
- 4